3-Chlorobenzaldehyde
| Title | Journal |
|---|---|
| rac-3,9-Bis(3-chloro-phen-yl)-2,4,8,10-tetra-oxaspiro-[5.5]undeca-ne. | Acta crystallographica. Section E, Structure reports online 20111001 |
| 1-[(3-Chloro-phen-yl)(morpholin-4-yl)-meth-yl]naphthalen-2-ol. | Acta crystallographica. Section E, Structure reports online 20110701 |
| Dimethyl 2-(3-chloro-phen-yl)-6-hy-droxy-6-methyl-4-(methyl-amino)-cyclo-hex-3-ene-1,3-dicarboxyl-ate. | Acta crystallographica. Section E, Structure reports online 20110601 |
| (E)-1-{4-[(E)-3-Chloro-benzyl-idene-amino]-phen-yl}-3-(3-chloro-phen-yl)prop-2-en-1-one. | Acta crystallographica. Section E, Structure reports online 20110501 |
| Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction. | Journal of medicinal chemistry 20110414 |
| (E)-2-(3-Chloro-benzyl-idene)-5,6-dimeth-oxy-2,3-dihydro-1H-inden-1-one. | Acta crystallographica. Section E, Structure reports online 20101101 |
| Dibut-yl{N'-[1-(5-chloro-2-oxidophenyl-κO)ethyl-idene]-3-hy-droxy-2-naphtho-hydrazidato-κN',O}tin(IV). | Acta crystallographica. Section E, Structure reports online 20100701 |
| (E)-3-(3-Chloro-phen-yl)-1-(4-methoxy-phen-yl)prop-2-en-1-one. | Acta crystallographica. Section E, Structure reports online 20100601 |
| [N'-(5-Chloro-2-oxidobenzyl-idene-κO)-3-hydr-oxy-2-naphthohydrazidato-κN',O]diphenyl-tin(IV). | Acta crystallographica. Section E, Structure reports online 20091201 |
| 3-(3-Chloro-phen-yl)-N-phenyl-oxirane-2-carboxamide. | Acta crystallographica. Section E, Structure reports online 20091201 |
| 7-Chloro-4-[(E)-(3-chloro-benzyl-idene)hydrazinyl]-1λ-quinolinium 3-chloro-benzoate. | Acta crystallographica. Section E, Structure reports online 20091201 |
| Ethyl 2-[(Z)-3-chloro-benzyl-idene]-7-methyl-3-oxo-5-phenyl-2,3-dihydro-5H-1,3-thia-zolo[3,2-a]pyrimidine-6-carboxyl-ate. | Acta crystallographica. Section E, Structure reports online 20080401 |
| Application of the Lewis acid-Lewis base bifunctional asymmetric catalysts to pharmaceutical syntheses: stereoselective chiral building block syntheses of human immunodeficiency virus (HIV) protease inhibitor and beta3-adenergic receptor agonist. | Chemical & pharmaceutical bulletin 20030601 |
| Capillary gas chromatography determination of benzaldehyde arising from benzyl alcohol used as preservative in injectable formulations. | Journal of pharmaceutical and biomedical analysis 20030326 |